Earnings Breakdown: TScan Therapeutics Q4
Benzinga Insights 8 months ago
Earnings
TScan Therapeutics (NASDAQ:TCRX) announced its Q4 earnings on Wednesday, March 4, 2026 at 07:00 AM.
Here's a breakdown of the earnings report.
Earnings
TScan Therapeutics beat estimated earnings by 33.33%, reporting an EPS of $-0.18 versus an estimate of $-0.27.
Revenue was up $1.90 million from the same period last year.
Analysis of Past Earnings
The company beat on EPS by $0.06 in the previous quarter, leading to a 5.04% drop share price change the next day.
Here's a look at TScan Therapeutics's past performance:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.34 | -0.31 | -0.28 | -0.28 |
| EPS Actual | -0.28 | -0.28 | -0.26 | -0.29 |
| Revenue Estimate | 2.47M | 1.56M | 1.08M | 1.51M |
| Revenue Actual | 2.51M | 3.08M | 2.17M | 665K |
Listen to the earnings announcement yourself by clicking here.
To track all earnings releases for TScan Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.